Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Toxicol Pathol. 2021 Feb 12;49(5):996–1023. doi: 10.1177/0192623320985045

Table 1:

Human Clinical Research Biomarkers Evaluated in Chronic Kidney Injury and Disease in Animals

Marker Matrix Source Usage Veterinary Diagnostics Veterinary Research Preclinical Research
KIM-1 Urine ↑PCT Released Tubular Injury/Regeneration X X X
KIM-1 Blood ↑PCT Released Tubular Injury/Regeneration - X -a
NGAL Urine ↑Tubular Released Tubular Injury/Regeneration X X X
NGAL Blood ↑Tubular Released Tubular Injury/Regeneration X X -
CysC Urine ↓PCT Resorption Tubular Injury X X X
CysC Blood Glomerular Filtration eGFR X X -a
SDMA Blood Glomerular Filtration eGFR X X X
DKK3 Urine ↑Tubular Released Tubular Injury/Fibrosis - X X
DKK3 Blood ↑Tubular Released Tubular Injury/Fibrosis - X X
B2M Urine ↓PCT Resorption Tubular Injury - X -a
B2M Blood Glomerular Filtration eGFR - X -a
UMOD Urine ↓TAL/DT Released Tubular Injury/Fibrosis - X -a
UMOD Blood ↓TAL/DT Released Tubular Injury/Fibrosis - - -
BTP Blood Glomerular Filtration eGFR - - -
a

Acute kidney injury reports published, but no chronic injury usage reported. KIM-1: kidney injury molecule 1, NGAL: neutrophil gelatinase-associated lipocalin, CysC: cystatin C, SMDA: symmetric dimethylarginine, DKK3: dickkopf homolog 3, B2M: beta-2 microglobulin, BTP: beta trace protein, UMOD: uromodulin, PCT: proximal convoluted tubule, TAL: thick ascending limb, DT: distal tubule, eGFR: estimated glomerular filtration rate